全氟丁烷超声造影在肝细胞癌病灶检出、微波消融引导及疗效评估中的作用
单中心前瞻性研究纳入26例患者共40个肝细胞癌病灶,术前用Sonazoid超声造影的Kupffer期检出4个(10%)灰阶超声未显示的额外病灶并引导微波消融,消融后3小时超声造影评估均达完全缓解,1个月按LR-TR标准技术有效率为95%,作者认为Sonazoid超声造影因Kupffer期稳定且病灶显示清晰,是精准穿刺消融的优良方法。
要点
- 术前Kupffer期超声造影较灰阶超声额外检出4个(10%)病灶。
- 所有病灶在消融后3小时超声造影均表现为完全缓解。
- 1个月随访按LR-TR标准技术有效率为95%。
核心结论
- 作者认为,Sonazoid超声造影因Kupffer期稳定且病灶显示清晰,是微波消融精准穿刺置针的优良方法。
研究设计与样本
- 单中心前瞻性研究,连续纳入2021年10月至11月计划行微波消融的肝细胞癌患者26例(24男2女,平均年龄61.38±9.76岁)共40个病灶(平均肿瘤直径21.4±7.7 mm);术前用Sonazoid行血管期和Kupffer期超声造影,消融后3小时重复超声造影,1个月行多期增强CT或动态增强MRI随访对比。
关键影像表现/征象
- 术前Kupffer期超声造影较灰阶超声额外检出4个(10%)病灶,这些病灶在术前影像上可见。
- 所有病灶在消融后3小时超声造影均显示完全缓解。
诊断标准与关键数值
- 消融后3小时超声造影采用肝脏影像报告和数据系统治疗反应标准(LR-TR)评估,所有病灶均为完全缓解。
- 1个月随访按LR-TR标准技术有效率为95%。
临床应用与阅片要点
- 术前Sonazoid超声造影Kupffer期可用于检出灰阶超声未显示的病灶。
- Kupffer期可用于引导微波消融的精准穿刺置针。
- 消融后3小时超声造影可按LR-TR标准评估治疗反应。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To evaluate role of perfluorobutane in guiding microwave ablation of HCC and to compare treatment response at 3 h of ablation using contrast-enhanced US (CEUS) with Sonazoid with 1-month follow-up contrast-enhanced CT/MRI.
METHODS: This was a single center prospective study and consecutive patients planned for microwave ablation of HCC from October to November 2021 were enrolled. Pre-procedure CEUS were performed using Sonazoid in both vascular and Kupffer phase and number of Kupffer defects compared with gray scale US. Precise needle placement of microwave applicator was done in the Kupffer phase. 3 hours post ablation CEUS was repeated to evaluate response assessment using Liver Imaging Reporting and Data System Treatment Response criteria (LR TR). One-month follow-up imaging was done using multiphasic CECT/dynamic CEMRI and comparison was done with post procedure CEUS.Please confirm if the author names are presented accurately and in the correct sequence (given name, middle name/initial, family name). Author 5 Given name: [Manoj Kumar] Last name [Sharma]. Author 6 Given name: [Shiv Kumar] Last name [Sarin]. Also, kindly confirm the details in the metadata are correct. all the names and affiliations are correct RESULTS: A total of 26 patients (24 males and 2 females, mean age 61.38 ± 9.76 years) having 40 lesions, of mean tumor diameter 21.4 ± 7.7 mm, underwent CEUS and ablation. Most common etiology for cirrhosis was viral hepatitis, followed by non-alcoholic steatohepatitis (NASH). Four (10%) additional lesions (which were seen on pre-procedure imaging) were detected in Kupffer phase over gray scale US. All lesions showed complete response in the immediate post procedure CEUS. Technique efficacy at 1-month was 95% according to the LR TR criteria.Please check the edit made in article title and amend if necessary.The edit is correct and appropriatePlease check and confirm that the authors and their respective affiliations have been correctly identified and amend if necessary.All the names and their respective affiliations are correct CONCLUSION: CEUS with Sonazoid is an excellent modality for precise needle placement for ablation due to stable nature and excellent lesion visibility of Kupffer phase.
引用
- Mukund, Bansal, Patidar, et al. Role of contrast-enhanced ultrasound with Perfluorobutane in lesion detection, guidance for microwave ablation, and response assessment of hepatocellular carcinoma. Abdom Radiol (NY). 2022. PMID: 35842563. doi:10.1007/s00261-022-03609-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。